{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-064544","form_type":"8-K","ticker":"NNVC","cik":"0001379006","company_name":"NANOVIRICIDES, INC.","filed_at":"2026-05-20T20:30:33+00:00","discovered_at":"2026-05-20T20:32:00.246717+00:00","generated_at":"2026-05-20T20:34:15.602402+00:00","sec_items":["1.01","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"NanoViricides raises $2M in registered direct offering of shares and warrants","bullets":["Offering of 1,333,334 shares (or pre-funded warrants) plus 1,333,334 warrants at $1.75, priced at $1.50 per share.","Gross proceeds $2,000,001; closed May 18, 2026; D. Boral Capital as placement agent.","Single institutional investor purchased entire offering; CEO agreed to 30-day lock-up.","Net proceeds to fund working capital, R&D, and clinical trial expenses."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-064544","json":"https://secwatch.observer/filing/0001104659-26-064544.json","markdown":"https://secwatch.observer/filing/0001104659-26-064544.md","text":"https://secwatch.observer/filing/0001104659-26-064544.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1379006/000110465926064544/0001104659-26-064544-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1379006/000110465926064544/tm2615013d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-20T20:34:15.602402+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"608c14f8d76c00624d00c2445e3a323d93eda64b","claim":"NANOVIRICIDES, INC. entered into Placement Agency Agreement with D. Boral Capital LLC (the \"Placement Agent\") (effective 2026-05-15).","evidence_excerpt":"the Company entered into a Placement Agency Agreement with D. Boral Capital LLC (the \"Placement Agent\"), dated May 15, 2026, pursuant to which the Placement Agent acted as the exclusive placement agent for the Company in connection with the Offering (the \"Placement Agency Agreement\")","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1379006/000110465926064544/0001104659-26-064544-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"D. Boral Capital LLC (the \"Placement Agent\")"},{"label":"Effective","value":"2026-05-15"}],"fact_type":"material_agreement"},{"claim_id":"6db2aa41f091332f22753ac72f88b0d1ccc25d13","claim":"NANOVIRICIDES, INC. entered into Securities Purchase Agreement with a certain purchaser (the \"Investor\") valued at approximately $2.0 million (effective 2026-05-15).","evidence_excerpt":"On May 15, 2026, NanoViricides, Inc. (the \"Company\") and a certain purchaser (the \"Investor\") entered into a securities purchase agreement (the \"Securities Purchase Agreement\")","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1379006/000110465926064544/0001104659-26-064544-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"a certain purchaser (the \"Investor\")"},{"label":"Value","value":"approximately $2.0 million"},{"label":"Effective","value":"2026-05-15"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}